Cargando…
Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice
BACKGROUND: The receptor for advanced glycation end-products (RAGE) has been suggested to modulate lung injury in models of acute pulmonary inflammation. To study this further, model systems utilizing wild type and RAGE knockout (KO) mice were used to determine the role of RAGE signaling in lipopoly...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100338/ https://www.ncbi.nlm.nih.gov/pubmed/21629785 http://dx.doi.org/10.1371/journal.pone.0020132 |
_version_ | 1782204186521239552 |
---|---|
author | Ramsgaard, Lasse Englert, Judson M. Manni, Michelle L. Milutinovic, Pavle S. Gefter, Julia Tobolewski, Jacob Crum, Lauren Coudriet, Gina M. Piganelli, Jon Zamora, Ruben Vodovotz, Yoram Enghild, Jan J. Oury, Tim D. |
author_facet | Ramsgaard, Lasse Englert, Judson M. Manni, Michelle L. Milutinovic, Pavle S. Gefter, Julia Tobolewski, Jacob Crum, Lauren Coudriet, Gina M. Piganelli, Jon Zamora, Ruben Vodovotz, Yoram Enghild, Jan J. Oury, Tim D. |
author_sort | Ramsgaard, Lasse |
collection | PubMed |
description | BACKGROUND: The receptor for advanced glycation end-products (RAGE) has been suggested to modulate lung injury in models of acute pulmonary inflammation. To study this further, model systems utilizing wild type and RAGE knockout (KO) mice were used to determine the role of RAGE signaling in lipopolysaccharide (LPS) and E. coli induced acute pulmonary inflammation. The effect of intraperitoneal (i.p.) and intratracheal (i.t.) administration of mouse soluble RAGE on E. coli injury was also investigated. METHODOLOGY/PRINCIPAL FINDINGS: C57BL/6 wild type and RAGE KO mice received an i.t. instillation of LPS, E. coli, or vehicle control. Some groups also received i.p. or i.t. administration of mouse soluble RAGE. After 24 hours, the role of RAGE expression on inflammation was assessed by comparing responses in wild type and RAGE KO. RAGE protein levels decreased in wild type lung homogenates after treatment with either LPS or bacteria. In addition, soluble RAGE and HMGB1 increased in the BALF after E. coli instillation. RAGE KO mice challenged with LPS had the same degree of inflammation as wild type mice. However, when challenged with E. coli, RAGE KO mice had significantly less inflammation when compared to wild type mice. Most cytokine levels were lower in the BALF of RAGE KO mice compared to wild type mice after E. coli injury, while only monocyte chemotactic protein-1, MCP-1, was lower after LPS challenge. Neither i.p. nor i.t. administration of mouse soluble RAGE attenuated the severity of E. coli injury in wild type mice. CONCLUSIONS/SIGNIFICANCE: Lack of RAGE in the lung does not protect against LPS induced acute pulmonary inflammation, but attenuates injury following live E. coli challenge. These findings suggest that RAGE mediates responses to E. coli-associated pathogen-associated molecular pattern molecules other than LPS or other bacterial specific signaling responses. Soluble RAGE treatment had no effect on inflammation. |
format | Text |
id | pubmed-3100338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-31003382011-05-31 Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice Ramsgaard, Lasse Englert, Judson M. Manni, Michelle L. Milutinovic, Pavle S. Gefter, Julia Tobolewski, Jacob Crum, Lauren Coudriet, Gina M. Piganelli, Jon Zamora, Ruben Vodovotz, Yoram Enghild, Jan J. Oury, Tim D. PLoS One Research Article BACKGROUND: The receptor for advanced glycation end-products (RAGE) has been suggested to modulate lung injury in models of acute pulmonary inflammation. To study this further, model systems utilizing wild type and RAGE knockout (KO) mice were used to determine the role of RAGE signaling in lipopolysaccharide (LPS) and E. coli induced acute pulmonary inflammation. The effect of intraperitoneal (i.p.) and intratracheal (i.t.) administration of mouse soluble RAGE on E. coli injury was also investigated. METHODOLOGY/PRINCIPAL FINDINGS: C57BL/6 wild type and RAGE KO mice received an i.t. instillation of LPS, E. coli, or vehicle control. Some groups also received i.p. or i.t. administration of mouse soluble RAGE. After 24 hours, the role of RAGE expression on inflammation was assessed by comparing responses in wild type and RAGE KO. RAGE protein levels decreased in wild type lung homogenates after treatment with either LPS or bacteria. In addition, soluble RAGE and HMGB1 increased in the BALF after E. coli instillation. RAGE KO mice challenged with LPS had the same degree of inflammation as wild type mice. However, when challenged with E. coli, RAGE KO mice had significantly less inflammation when compared to wild type mice. Most cytokine levels were lower in the BALF of RAGE KO mice compared to wild type mice after E. coli injury, while only monocyte chemotactic protein-1, MCP-1, was lower after LPS challenge. Neither i.p. nor i.t. administration of mouse soluble RAGE attenuated the severity of E. coli injury in wild type mice. CONCLUSIONS/SIGNIFICANCE: Lack of RAGE in the lung does not protect against LPS induced acute pulmonary inflammation, but attenuates injury following live E. coli challenge. These findings suggest that RAGE mediates responses to E. coli-associated pathogen-associated molecular pattern molecules other than LPS or other bacterial specific signaling responses. Soluble RAGE treatment had no effect on inflammation. Public Library of Science 2011-05-23 /pmc/articles/PMC3100338/ /pubmed/21629785 http://dx.doi.org/10.1371/journal.pone.0020132 Text en Ramsgaard et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Ramsgaard, Lasse Englert, Judson M. Manni, Michelle L. Milutinovic, Pavle S. Gefter, Julia Tobolewski, Jacob Crum, Lauren Coudriet, Gina M. Piganelli, Jon Zamora, Ruben Vodovotz, Yoram Enghild, Jan J. Oury, Tim D. Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice |
title | Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice |
title_full | Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice |
title_fullStr | Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice |
title_full_unstemmed | Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice |
title_short | Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice |
title_sort | lack of the receptor for advanced glycation end-products attenuates e. coli pneumonia in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100338/ https://www.ncbi.nlm.nih.gov/pubmed/21629785 http://dx.doi.org/10.1371/journal.pone.0020132 |
work_keys_str_mv | AT ramsgaardlasse lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT englertjudsonm lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT mannimichellel lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT milutinovicpavles lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT gefterjulia lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT tobolewskijacob lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT crumlauren lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT coudrietginam lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT piganellijon lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT zamoraruben lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT vodovotzyoram lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT enghildjanj lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice AT ourytimd lackofthereceptorforadvancedglycationendproductsattenuatesecolipneumoniainmice |